Structure-function studies of S-antigen: use of proteases to reveal a dominant uveitogenic site


Dua, H, Hossain, P, Brown, P A, McKinnon, A, Forrester, J , Gregerson, D and Donoso, L (1991) Structure-function studies of S-antigen: use of proteases to reveal a dominant uveitogenic site. Autoimmunity, 10, (2), 153-163. (PMID:1723632).

Download

Full text not available from this repository.

Description/Abstract

Retinal S-antigen induced experimental autoimmune uveitis (EAU) is a severe, predominantly T-cell mediated inflammatory disease of the uveal tract and retina of the eye. Pretreatment of LEW rats with the monoclonal antibody, MAbS2.4.C5, which defines an epitope in S-antigen, has been shown to effectively inhibit the subsequent induction of EAU with S-antigen. Using synthetic peptides and cyanogen bromide fragments of S-antigen we found the binding site of MAbS2.4.C5 to be located at the carboxy terminus of the molecule corresponding to amino acid positions 375 to 380. Limited Staphylococcus aureus V8 protease digestion yielded several polypeptide fragments including one large 43 kD fragment which retained antibody binding to a variety of both polyclonal and monoclonal antibodies which identify epitopes that span the length of the S-antigen. This treatment, however, completely destroys the MAbS2.4.C5 binding site and dramatically reduces uveitopathogenicity. Limited trypsin and papain digestion, on the other hand, had little effect on pathogenicity or on MAbS2.4.C5 binding to S-antigen or its peptide fragments. These results indicate that the carboxy-terminus of S-antigen plays a predominant role in the pathogenesis of EAU.

Item Type: Article
ISSNs: 0891-6934 (print)
1607-842X (electronic)
Subjects: Q Science > QR Microbiology > QR180 Immunology
R Medicine > RB Pathology
Divisions: University Structure - Pre August 2011 > School of Medicine > Infection, Inflammation and Repair
ePrint ID: 193075
Date Deposited: 12 Jul 2011 08:45
Last Modified: 27 Mar 2014 19:44
URI: http://eprints.soton.ac.uk/id/eprint/193075

Actions (login required)

View Item View Item